Discontinued — last reported Q4 '17
Palantir Technologies Inc. Intangibles (Net) decreased by 7.3% to $14.61M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from $19.49M to $14.61M. Over 2 years (FY 2022 to FY 2024), Intangibles (Net) shows a downward trend with a -28.7% CAGR.
High levels reflect significant investment in growth through acquisitions; changes indicate the impact of amortization or impairment charges.
This includes the value of acquired intellectual property, such as patents, trademarks, and drug licenses, net of accumu...
Very high in the pharmaceutical industry due to the reliance on patent-protected drug portfolios.
intangible_assets_net| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.54M | $33.13M | $30.72M | $28.31M | $25.90M | $23.49M | $21.47M | $19.49M | $18.06M | $16.91M | $15.76M | $14.61M |
| QoQ Change | — | -6.8% | -7.3% | -7.8% | -8.5% | -9.3% | -8.6% | -9.3% | -7.3% | -6.4% | -6.8% | -7.3% |
| YoY Change | — | — | — | — | -27.1% | -29.1% | -30.1% | -31.2% | -30.3% | -28.0% | -26.6% | -25.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.